Anamaria Orza1, Yi Yang2, Ting Feng3, Xueding Wang3, Hui Wu1, Yuancheng Li1, Lily Yang4, Xiangyang Tang2, Hui Mao1. 1. Department of Radiology and Imaging Sciences and Center for Systems Imaging, Emory University School of Medicine, Atlanta, Georgia 30322. 2. Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, Georgia 30322. 3. Department of Biomedical Engineering, University of Michigan School of Medicine, Ann Arbor, Michigan 48109. 4. Department of Surgery, Emory University School of Medicine, Atlanta, Georgia 30322.
Abstract
PURPOSE: To develop a core/shell nanodimer of gold (core) and silver iodine (shell) as a dual-modal contrast-enhancing agent for biomarker targeted x-ray computed tomography (CT) and photoacoustic imaging (PAI) applications. METHODS: The gold and silver iodine core/shell nanodimer (Au/AgICSD) was prepared by fusing together components of gold, silver, and iodine. The physicochemical properties of Au/AgICSD were then characterized using different optical and imaging techniques (e.g., HR- transmission electron microscope, scanning transmission electron microscope, x-ray photoelectron spectroscopy, energy-dispersive x-ray spectroscopy, Z-potential, and UV-vis). The CT and PAI contrast-enhancing effects were tested and then compared with a clinically used CT contrast agent and Au nanoparticles. To confer biocompatibility and the capability for efficient biomarker targeting, the surface of the Au/AgICSD nanodimer was modified with the amphiphilic diblock polymer and then functionalized with transferrin for targeting transferrin receptor that is overexpressed in various cancer cells. Cytotoxicity of the prepared Au/AgICSD nanodimer was also tested with both normal and cancer cell lines. RESULTS: The characterizations of prepared Au/AgI core/shell nanostructure confirmed the formation of Au/AgICSD nanodimers. Au/AgICSD nanodimer is stable in physiological conditions for in vivo applications. Au/AgICSD nanodimer exhibited higher contrast enhancement in both CT and PAI for dual-modality imaging. Moreover, transferrin functionalized Au/AgICSD nanodimer showed specific binding to the tumor cells that have a high level of expression of the transferrin receptor. CONCLUSIONS: The developed Au/AgICSD nanodimer can be used as a potential biomarker targeted dual-modal contrast agent for both or combined CT and PAI molecular imaging.
PURPOSE: To develop a core/shell nanodimer of gold (core) and silver iodine (shell) as a dual-modal contrast-enhancing agent for biomarker targeted x-ray computed tomography (CT) and photoacoustic imaging (PAI) applications. METHODS: The gold and silver iodine core/shell nanodimer (Au/AgICSD) was prepared by fusing together components of gold, silver, and iodine. The physicochemical properties of Au/AgICSD were then characterized using different optical and imaging techniques (e.g., HR- transmission electron microscope, scanning transmission electron microscope, x-ray photoelectron spectroscopy, energy-dispersive x-ray spectroscopy, Z-potential, and UV-vis). The CT and PAI contrast-enhancing effects were tested and then compared with a clinically used CT contrast agent and Au nanoparticles. To confer biocompatibility and the capability for efficient biomarker targeting, the surface of the Au/AgICSD nanodimer was modified with the amphiphilic diblock polymer and then functionalized with transferrin for targeting transferrin receptor that is overexpressed in various cancer cells. Cytotoxicity of the prepared Au/AgICSD nanodimer was also tested with both normal and cancer cell lines. RESULTS: The characterizations of prepared Au/AgI core/shell nanostructure confirmed the formation of Au/AgICSD nanodimers. Au/AgICSD nanodimer is stable in physiological conditions for in vivo applications. Au/AgICSD nanodimer exhibited higher contrast enhancement in both CT and PAI for dual-modality imaging. Moreover, transferrin functionalized Au/AgICSD nanodimer showed specific binding to the tumor cells that have a high level of expression of the transferrin receptor. CONCLUSIONS: The developed Au/AgICSD nanodimer can be used as a potential biomarker targeted dual-modal contrast agent for both or combined CT and PAI molecular imaging.
Authors: Christian P Karger; Peter Hipp; Marcus Henze; Gernot Echner; Angelika Höss; Lothar Schad; Günther H Hartmann Journal: Phys Med Biol Date: 2003-01-21 Impact factor: 3.609
Authors: Lakshmi Sampath; Sunkuk Kwon; Shi Ke; Wei Wang; Rachel Schiff; Michel E Mawad; Eva M Sevick-Muraca Journal: J Nucl Med Date: 2007-09 Impact factor: 10.057
Authors: Christian Freese; Chiara Uboldi; Matthew I Gibson; Ronald E Unger; Babette B Weksler; Ignacio A Romero; Pierre-Olivier Couraud; C James Kirkpatrick Journal: Part Fibre Toxicol Date: 2012-07-03 Impact factor: 9.400
Authors: Emmy Yang; Weiping Qian; Zehong Cao; Liya Wang; Erica N Bozeman; Christina Ward; Bin Yang; Periasamy Selvaraj; Malgorzata Lipowska; Y Andrew Wang; Hui Mao; Lily Yang Journal: Theranostics Date: 2015-01-01 Impact factor: 11.556
Authors: Rabee Cheheltani; Rami M Ezzibdeh; Peter Chhour; Kumidini Pulaparthi; Johoon Kim; Martina Jurcova; Jessica C Hsu; Cassidy Blundell; Harold I Litt; Victor A Ferrari; Harry R Allcock; Chandra M Sehgal; David P Cormode Journal: Biomaterials Date: 2016-06-07 Impact factor: 12.479
Authors: Maryam Hajfathalian; Ahmad Amirshaghaghi; Pratap C Naha; Peter Chhour; Jessica C Hsu; Keely Douglas; Yuxi Dong; Chandra M Sehgal; Andrew Tsourkas; Svetlana Neretina; David P Cormode Journal: Nanoscale Date: 2018-10-02 Impact factor: 7.790